Moderna has announced a $140 million investment to enhance its Massachusetts manufacturing capacity, a move that supports ...

Regeneron announced the FDA’s approval of two indications of Eylea HD, including an 8mg injection for patients with macular ...

Cancerguard, a multi-cancer early detection blood test.

In the first part of our conversation with Ryan Conrad, visiting fellow at the Center on Health Policy at the Brookings ...

AbbVie and Genmab have received FDA approval for Epkinly as a treatment option for patients with relapsed or refractory follicular lymphoma. The decision adds a new targeted immunotherapy to the ...

Just a few weeks after the company announced licensing agreements with Empirico and Syndivia, GSK announced a strategic ...

Discover how AI-powered patient intelligence is ushering in a new era of pharma leadership defined by clarity, speed, and ...

This series kicks off by introducing David Edelman, Founder & CEO of Thrivable, who joins Pharmaceutical Executive to discuss ...

David Edelman, Founder & CEO of Thrivable, provides an unflinching look at why today’s most relied-upon tools, including ...

Learn how outdated or incomplete insights turn every decision into a high-stakes gamble that cost brands money, momentum, and ...

Understand how real-time patient intelligence transforms leadership conversations from speculation and opinion battles into ...

This episode acts as a peek inside the modern pharma boardroom, where leaders are expected to defend billion-dollar brands ...